Collegeville, PA, United States of America

Pamela A Haile

USPTO Granted Patents = 10 (Patent Applications = 9)

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 8 (Patent Applications = 11)

Average Co-Inventor Count = 5.9

ph-index = 3

Forward Citations = 23(Granted Patents)

Location History:

King of Prussia, PA (US) (2010 - 2013)
Collegeville, PA (US) (2013 - 2019)

Company Filing History:

7 out of 230

Glaxosmithkline Intellectual Property Development Limited

Years Active: 2010-2019

Loading Chart...

10 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 10220030 - Amino-quinolines as kinase inhibitors (2019-03-05),

2. 9994529 - Amino quinazolines as kinase inhibitors (2018-06-12),

3. 9650364 - Quinazolines as kinase inhibitors (2017-05-16),

4. 9604963 - Amino-quinolines as kinase inhibitors (2017-03-28),

5. 9604938 - Amino quinazolines as kinase inhibitors (2017-03-28),

6. 9586953 - Prodrugs of amino quinazoline kinase inhibitor (2017-03-07),

7. 9216965 - Amino-quinolines as kinase inhibitors (2015-12-22),

8. 8563722 - Stereoselective hydrogenation of a ketone (2013-10-22),

9. 8431590 - Spiroindolines as modulators of chemokine receptors (2013-04-30),

10. 7723350 - Spiroindolines as modulators of chemokine receptors (2010-05-25),

Title: Innovations and Contributions of Pamela A. Haile

Introduction

Pamela A. Haile is a distinguished inventor based in Collegeville, PA, known for her significant contributions to the field of medicinal chemistry. With a total of 10 patents to her name, she has made remarkable strides in developing innovative compounds that serve as kinase inhibitors.

Latest Patents

Among her latest patents are "Amino-quinolines as kinase inhibitors," which disclose compounds with a specific formula aimed at inhibiting kinase activity. Additionally, she has developed "Amino quinazolines as kinase inhibitors," further expanding the arsenal of compounds available for therapeutic applications.

Career Highlights

Pamela has worked with notable companies such as GlaxoSmithKline Intellectual Property Development Limited and Glaxo Group Limited. Her experience in these organizations has allowed her to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Throughout her career, Pamela has collaborated with esteemed colleagues, including Linda N. Casillas and Robert Singhaus, Jr. These partnerships have fostered a collaborative environment that enhances innovation and drives research forward.

Conclusion

Pamela A. Haile's work exemplifies the impact of innovative thinking in the field of medicinal chemistry. Her patents and collaborations highlight her commitment to advancing healthcare through scientific discovery.

This text is generated by artificial intelligence and may not be accurate.